Answers are grounded in this paper and cite their sources.
The scientific field of microcarrier systems has gained significant advancements, especially in drug delivery and controlled release mechanisms. This manuscript provides a comprehensive overview of the progress in developing pectin-derived microcarriers fabricated using microfluidic technology. Pectin, a naturally occurring polysaccharide, has garnered attention due to its biocompatibility, biodegradability, and ability to form hydrogels, making it an ideal candidate for forming microcarriers. The integration of microfluidic technology in synthesizing these carriers has revolutionized their design and functionality, enabling precise control over size, morphology, and encapsulation efficiency. This review systematically analyzes the methodologies employed in the microfluidic fabrication of pectin-based microparticles, highlighting the significant advantages this technology offers, such as reduced use of solvents, enhanced reproducibility, and scalability.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: